Effects of oral contraceptives and menopausal hormone therapy on the risk of rheumatoid arthritis: a prospective cohort study.

Hadizadeh, Fatemeh; Johansson, Therese; Johansson, Åsa; Karlsson, Torgny; Ek, Weronica E

Hadizadeh, Fatemeh; Johansson, Therese; Johansson, Åsa; Karlsson, Torgny; Ek, Weronica E.

Afiliación

Hadizadeh F; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Box 815, Uppsala, 75108, Sweden.
Johansson T; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Box 815, Uppsala, 75108, Sweden.
Johansson Å; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Box 815, Uppsala, 75108, Sweden.
Karlsson T; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Box 815, Uppsala, 75108, Sweden.
Ek WE; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Box 815, Uppsala, 75108, Sweden.

Rheumatology (Oxford) ; 2023 Sep 29.

Article en En | MEDLINE | ID: mdl-37773999

Palabras clave

LORA; Late-onset RA; Menopausal hormone therapy; Oral contraceptive; Rheumatoid arthritis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Suecia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google